Clinical Trials at Children's Hospital Medical Center of Akron
As of August 2026, 26 paid clinical trials are recruiting at Children's Hospital Medical Center of Akron, located at 1 PERKINS SQ, AKRON, OH 44308-1062, phone (330) 543-8171 in Akron, Ohio. Active studies at this site cover conditions such as Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
26 clinical trials at Children's Hospital Medical Center of Akron
·Clear filters·Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Project: Every Child for Younger Patients With Cancer
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Common conditions studied in Akron
- Acute Myeloid Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Breast Cancer (3 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Stroke (3 active studies)
- Acute Lymphoblastic Leukemia (2 active studies)
Leading research sponsors in Akron
- Children's Oncology Group
- National Cancer Institute (NCI)
- NRG Oncology
- Akron Children's Hospital
- Children's Hospital of Philadelphia
Frequently asked questions
How many paid clinical trials are currently recruiting in Akron?
There are approximately 121 recruiting clinical trials in Akron, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Akron pay participants?
Most recruiting trials in Akron compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Akron?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Akron?
The most common conditions under active study in Akron include Acute Myeloid Leukemia (3), B Acute Lymphoblastic Leukemia (3), Breast Cancer (3), Malignant Solid Neoplasm (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Akron?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Akron on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Akron?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Akron?
Recruiting research sites in Akron include Akron Children's Hospital, Children's Hospital Medical Center of Akron, Cleveland Clinic Akron General, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Akron right now?
The largest active categories in Akron are Cancer & tumors (37), Cardiovascular (10), Neurology & pain (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Children's Hospital Medical Center of Akron?
Children's Hospital Medical Center of Akron is located at 1 PERKINS SQ, AKRON, OH 44308-1062. Use the Google Maps link in the intro above to get directions.
How do I contact Children's Hospital Medical Center of Akron?
You can reach Children's Hospital Medical Center of Akron by phone at (330) 543-8171. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.